CKD is less prevalent in dogs than in cats but is more likely to be progressive and life-limiting. The aetiology of CKD is more varied in dogs, and it is useful to understand when a renal biopsy will help to inform treatment decisions. In this webinar, we will use case examples and evidence-based medicine to discuss the aetiology of CKD in dogs, differences in the IRIS staging system for dogs versus cats and the treatment recommendations for this species.
Rebecca graduated from Cambridge University in 2007. She completed her PhD in 2014 at the Royal Veterinary College examining "Calcium-phosphate homeostasis in feline chronic kidney disease". Rebecca subsequently completed her internship and internal medicine residency at the Royal Veterinary College and now works there as a Senior Lecturer in Small Animal Internal Medicine. She gained her Diploma in Small Animal Internal Medicine in 2018, became a Fellow of the Higher Education Academy in 2019, an RCVS Specialist in 2020, and gained her Diploma in Veterinary Nephrology and Urology in 2025. She spends half of her time in the clinic with canine and feline internal medicine cases. Her current research interests include CKD, CKD-mineral and bone disorder, hypercalcaemia and nephrolithiasis in cats.